Johannes Oldenburg

14PUBLICATIONS
36CO-AUTHORS
Immunogenetics (incl. genetic immunology)HaematologyHypersonic propulsion and hypersonic aerothermodynamicsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Innate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|May 13, 2022
Safety of intramuscular COVID-19 vaccination in patients with haemophilia.

Andreas Tiede, Hendrik Leise, Silvia Horneff

|Mar 09, 2022
Quality of life in a large multinational haemophilia B cohort (The B-Natural study) - Unmet needs remain.

Erik Berntorp, Petra LeBeau, Margaret V Ragni

|Dec 05, 2020
Natural history study of factor IX deficiency with focus on treatment and complications (B-Natural).

Amy D Shapiro, Margaret V Ragni, Munira Borhany

|Oct 21, 2020
Quality of electronic treatment records and adherence to prophylaxis in haemophilia and von Willebrand disease: Systematic assessments from an electronic diary.

Andreas Tiede, Santiago Bonanad, Amparo Santamaria

|Jun 05, 2020
Long-term safety and sustained efficacy for up to 5 years of treatment with recombinant factor IX Fc fusion protein in subjects with haemophilia B: Results from the B-YOND extension study.

K John Pasi, Kathelijn Fischer, Margaret Ragni

|Apr 01, 2020
Recombinant factor VIII Fc fusion protein for the treatment of severe haemophilia A: Final results from the ASPIRE extension study.

Beatrice Nolan, Johnny Mahlangu, Ingrid Pabinger

Pageof 3